Work

 

Elcelyx

Elcelyx Therapeutics is developing Type 2 Diabetes therapeutics to modulate the gut neuroendocrine system including the L-cell, which when activated is responsible for release of glucose-regulatory hormones. As their clinical trials advance so does their recognition. In preparation for higher visibility AldenMC re-designed their identity and website.

Identity

Elcelyx

Presentations

Presentation Piece 1